Article
MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
PloS one - 1 Jan 2022
Omar Intan Sofia, Abd Jamil Amira Hajirah, Mat Adenan Noor Azmi, Chung Ivy
Abstract excerpt
Obese women have a higher risk of developing endometrial cancer (EC) than lean women. Besides affecting EC progression, obesity also affects sensitivity of patients to treatment including medroxprogesterone acetate (MPA). Obese women have a lower response to MPA with an increased risk for tumor recurrence. While MPA inhibits the growth of normal fibroblasts, human endometrial cancer-associated fibroblasts (CAFs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
